WHA74

May 2021
Geneva

Agenda

2
Report of the Executive Board on its 147th and 148th sessions, and on its special session on the COVID-19 response
3
Address by Dr Tedros Adhanom Ghebreyesus, Director-General2
4
Invited speaker(s)
6
Executive Board: election
7
Awards
8
Reports of the main committees
10
Opening of Committee A
13.2
Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases: oral health
13.3
Expanding access to effective treatments for cancer and rare and orphan diseases, including medicines, vaccines, medical devices, diagnostics, assistive products, cell- and gene-based therapies and other health technologies; and improving the transpa
13.5
Antimicrobial resistance
13.6
Substandard and falsified medical products
13.7
Standardization of medical devices nomenclature
16
Committing to implementation of the Global Strategy for Women’s, Children’s and Adolescents’ Health (2016−2030)
17.2
Independent Oversight and Advisory Committee for the WHO Health Emergencies Programme
20
Enhancement of laboratory biosafety
22
Review of and update on Pillar 3 matters considered by the Executive Board
24
Opening of Committee B
25
Health conditions in the occupied Palestinian territory, including east Jerusalem, and in the occupied Syrian Golan
26
Review of and update on matters considered by the Executive Board: Managerial, administrative and governance matters
26.6
Human resources: annual report
26.7
Report of the International Civil Service Commission
27
Appointment of representatives to the WHO Staff Pension Committee
28
Report of the United Nations Joint Staff Pension Board
29.4
Scale of assessments 2022–2023
30.1
Report of External Auditor
30.3
Audit recommendations: progress on implementation
31
Management and legal matters
32
Collaboration within the United Nations system and with other intergovernmental organizations
34
Matters for information